Employees Retirement System of Texas’s Neurocrine Biosciences NBIX Stock Holding History

Employees Retirement System of Texas’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,059	Closed	-$150K	–	550
2025 Q4	$150K	Hold	1,059	–	–	﹤0.01%	354
2025 Q3	$149K	Buy	+1,059	New	+$143K	﹤0.01%	358
2022 Q3	–	Sell	-8,018	Closed	-$782K	–	571
2022 Q2	$782K	Hold	8,018	–	–	0.01%	637
2022 Q1	$752K	Hold	8,018	–	–	0.01%	675
2021 Q4	$683K	Hold	8,018	–	–	0.01%	695
2021 Q3	$769K	Hold	8,018	–	–	0.01%	724
2021 Q2	$780K	Hold	8,018	–	–	0.01%	687
2021 Q1	$780K	Hold	8,018	–	–	0.01%	691
2020 Q4	$769K	Hold	8,018	–	–	0.01%	599
2020 Q3	$771K	Hold	8,018	–	–	0.01%	656
2020 Q2	$978K	Hold	8,018	–	–	0.01%	645
2020 Q1	$694K	Sell	8,018 -32,400	-80%	-$3.17M	0.01%	644
2019 Q4	$4.34M	Hold	40,418	–	–	0.07%	325
2019 Q3	$3.64M	Buy	+40,418	New	+$3.78M	0.06%	359

Other funds holding NBIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Employees Retirement System of Texas's NBIX Position: Q1 2026 in Review

Employees Retirement System of Texas sold out of Neurocrine Biosciences (NBIX) in Q1 2026, closing a stake of 1,059 shares — an estimated $150K sold.

Employees Retirement System of Texas first reported a position in NBIX in Q3 2019 and held it in 14 quarters. The position peaked at $4.34M in Q4 2019. 695 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

Employees Retirement System of Texas reported no remaining Neurocrine Biosciences position as of Q1 2026 after selling out during the quarter.
Employees Retirement System of Texas sold 1,059 Neurocrine Biosciences shares in Q1 2026, an estimated $150K.
Employees Retirement System of Texas first reported a position in Neurocrine Biosciences in Q3 2019 and held it in 14 quarters.
Employees Retirement System of Texas's Neurocrine Biosciences position peaked at $4.34M in Q4 2019.
695 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Employees Retirement System of Texas's 13F filing for Q1 2026, filed 13 May 2026.